← SynDRA
ETAZOLATE
SynDRA canonical compound SYN0005032 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PDE4A |
|---|
| Mechanism of action | Phosphodiesterase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Phosphodiesterase inhibitor
- GABRB3 POSITIVE ALLOSTERIC MODULATOR
- GABA receptor beta-3 subunit positive allosteric modulator
- GABRB3 BINDER
- GABRG3 MODULATOR
Drug classes
- Antipsychotic Agents
- Phosphodiesterase Inhibitors
Cross-references
Synonyms
- Etazolato
- EHT-0202
- SQ 20009
- Etazolate hydrochloride
- SQ-20009
- Etazolatum
- I89Y79062L
- CHEBI:138502
- RefChem:137999
- DTXCID0028408
- Etazolate [INN]
- Etazolatum [INN-Latin]
- Etazolato [INN-Spanish]
- NSC163611
- SQ 20,009
- UNII-I89Y79062L
- Tocris-0438
- Lopac-E-1896
- Lopac0_000440
- Etazolate hydrochloride(USAN)
- SCHEMBL123840
- GTPL7336
- orb1740309
- SCHEMBL29824913
- CHEBI:93135
- EHT-202
- OPQRBXUBWHDHPQ-UHFFFAOYSA-N
- HMS2090J08
- Tox21 111226
- BDBM50225504
- HSCI1_000299
- CCG-204532
- FE22846
- SB16896
- SDCCGSBI-0050425.P002
- NCGC00015403-01
- NCGC00015403-02
- NCGC00015403-03
Look up ETAZOLATE in the interactive SynDRA portal →